Brief: Aridis Says On May 3 Co Sent Notice To Serum Stating That As Of May 8, License, Development, Commercialization Agreement Between Co, Serum Would Terminate
09/05/2023 22:20
May 9 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS - ON MAY 3 CO SENT NOTICE TO SERUM STATING THAT AS
OF MAY
8, LICENSE, DEVELOPMENT, COMMERCIALIZATION AGREEMENT BETWEEN CO,
SERUM WOULD TERMINATE
Source text for Eikon: ID:
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music